Costimulatory pathways in multiple sclerosis: Distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease

Journal of Immunology

Volumn 183, Issue 8, 2009, Pages 4984-4993

  Trabattoni, Daria ^a   Saresella, Marina ^a   Pacei, Michela ^a   Marventano, Ivana ^b   Mendozzi, Laura ^b   Rovaris, Marco ^b   Caputo, Domenico ^b   Borelli, Manuela ^a   Clerici, Mario ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTIGEN PD L1; B7 ANTIGEN; BETA1A INTERFERON; CD14 ANTIGEN; CD19 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLATIRAMER; INTERFERON BETA SERINE; INTERLEUKIN 10; LIPOCORTIN 5; MYELIN BASIC PROTEIN; PROGRAMMED DEATH 1 RECEPTOR; UNCLASSIFIED DRUG;

ACUTE MULTIPLE SCLEROSIS; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RELAPSE; REMISSION; STABLE MULTIPLE SCLEROSIS;

ADULT; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; ONCOGENE PROTEIN V-AKT; PEPTIDES; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 77952080272     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901038     Document Type: Article

References (57)

1. Davis, M. M., and P. J. Bjorkman. 1988. T cell antigen receptor genes and T cell recognition. Nature 334: 395-402.
2. Dustin, M. L., and T. A. Springer. 1993. The role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu. Rev. Immunol. 9: 27-66.
3. Bugeon, L., and L. J. Dallman. 2000. Costimulation of T cell responses. Am. J. Respir. Crit. Car. Med. 62: 164-168.
4. Razi-Wolf, Z., G. J. Freeman, F. Galvin, B. Benacerraf, L. Nadler, and H. Reiser. 1992. Expression and function of the murine B7 antigen: the major costimulatory molecule expressed by peritoneal exudates cells. Proc. Natl. Acad. Sci. USA 89: 4210-4214.
5. Linsley, P. S., and J. A. Ledbetter. 1993. The role of CD28 receptor during T cell responses to antigens. Annu. Rev. Immunol. 11: 191-221.
6. Carreno, B. M., and M. Collins. 2002. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune response. Annu. Rev. Immunol. 20: 29-53.
7. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2: 116-126.
8. Coyle, A. J., and J. C. Gutierrez-Ramos. 2001. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2: 203-209.
9. Dong, H. D., G. Zhu, K. Tamada, and L. P. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5: 1365-1369.
10. Wang, S., G. Zhu, A. I. Chapoval, H. Dong, K. Tamada, J. Ni, and L. Chen. 2000. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 96: 2808-2813.
11. Freeman, G. J., A. J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192: 1027-1034.
12. Latchman, Y. E., C. R. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A. J. Long, J. A. Brown, R. Nunes, et al. 2001. PD-L2, a novel B7 homologue, is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2: 261-268.
13. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677-704.
14. Sharpe, A. H., E. J. Wherry, R. Ahmed, and G. J. Freeman. 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8: 239-245.
15. Salama, A. D., T. Chitinis, J. Imitola, M. J. Ansari, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198: 71-78.
16. Zhu, B., I. Guleria, A. Khosroshahi, T. Chitnis, J. Imitola, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2006. Differential role of programmed death-ligand 1 and programmed death-ligand 2 in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J. Immunol. 176: 3480-3489.
17. Carter, L. L., M. W. Leach, M. L. Azotei, J. Cui, J. W. Pelker, J. Jussif, S. Benoit, G. Ireland, D. Luxenberg, G. R. Askew, et al. 2007. PD-1/PD-L1, but not PD- 1/PD-L2, interaction regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 182: 124-134.
18. Ortler, S., C. Leder, M. Mittelbronn, A. L. Zozulya, P. A. Knolle, L. Chen, A. Kroner, and H. Wiendl. 2008. B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis. Eur. J. Immunol. 38: 1734-1744.
19. Pette, M., K. Fujita, B. Kitze, J. N. Whitaker, E. Albert, L. Kappos, and H. Wekerle. 1990. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40: 1770-1776.
20. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85: 299-302. (Pubitemid 26160700)
21. Noseworthy, J. H., C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker. 2000. Multiple sclerosis. N. Engl. J. Med. 343: 938-952.
22. Steinman, L. 2001. Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J. Exp. Med. 194: 27-30.
23. Pelfrey, C. M., L. R. Tranquill, S. A. Boehme, H. F. McFarland, and M. L. Lenardo. 1995. Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. J. Immunol. 154: 6191-6202.
24. Sharief, M. K., M. Douglas, M. Noori, and Y. K. Semra. 2002. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis. J. Neuroimmunol. 125: 155-162.
25. Saresella, M., Marventano, I., Speciale, L., S. Ruzzante, D. Trabattoni, S. Della Bella, M. Filippi, F. Fasano, R. Cavarretta, D. Caputo, M. Clerici, and P. Ferrante. 2005. Programmed cell death of myelin basic protein-specific T lymphocytes is reduced in patients with acute multiple sclerosis. J. Neuroimmunol. 166: 173-179.
26. Saresella, M., I. Marventano, and F. R. Guerini. 2008. Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases. Clin. Immunol. 129: 509-517.
27. Ferrante, P., M. L. Fusi, M. Saresella D. Caputo, M. Biasin, D. Trabattoni, A. Salvaggio, E. Clerici, J. E. de Vries, G. Aversa, C. L. Cazzullo, and M. Clerici. 1998. Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis. J. Immunol. 160: 1514-1521.
28. Clerici, M., M. Saresella, D. Trabattoni, L. Speciale, S. Fossati, S. Ruzzante, R. Cavaretta, M. Filippi, D. Caputo, and P. Ferrante. 2001. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease. J. Neuroimmunol. 121: 88-101.
29. Chapoval, A. I., J. Ni, J. S. Lau, R. A. Wilcox, D. B. Flies, D. Liu, H. Dong, G. L. Sica, G. Zhu, K. Tamada, and L. Chen. 2001. B7-H3: a costimulatory molecule for T cell activation and IFNγ production. Nat. Immunol. 2: 269-274.
30. Kurtze, J. F. 1983. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
31. Selenko-Gebauer, N., O. Majdic, A. Szekeres, G. Höfler, E. Guthann, U. Korthäuer, G. Zlabinger, P. Steinberger, W. F. Pickl, H. Stockinger, W. Knapp, and J. Stöckl. 2003. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 170: 3637-3644.
32. Dong, H., Strome, S. E., D. R. Salomao, H. Tamura, F. Hirano, D. B. Flies, P. C. Roche, J. Lu, G. Zhu, K. Tamada, V. A. Lennon, E. Celis and L. Chen. 2002. Tumor-associated B7-H1 promotes T cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8: 793-800.
33. Dong, H. D., and L. P. Chen. 2003. B7-H1 pathway and its role in the evasion of tumor immunity. J. Mol. Med. 81: 281-287.
34. Trabattoni, D., M. Saresella, M. Biasin, G. Maffeis, A. Boasso, H. Dong, L. Chen, and M. Clerici. 2002. B7-H1 is upregulated in HIV infection and is a novel surrogate marker of disease progression. Blood 101: 2514-2520.
35. + T cell survival in HIV infection. J. Exp. Med. 203: 2281-2292.
36. Keir, M. E., Y. E. Latchman, G. J. Freeman, and A. H. Sharpe. 2005. Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes. J. Immunol. 175: 7372-7379.
37. Blank, C., I. Brown, R. Marks, H. Nishimura, T. Honjo, and T. F. Gajewski. 2003. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells. J. Immunol. 171: 4574-4581.
38. Holets, L. M., J. S. Hunt, and M.G. Petroff. 2006. Trophoblast CD274 (B7-H1) is differentially expressed across gestation: influence of oxygen concentration. Biol. Reprod. 74: 352-358.
39. Guleria, I., A. Khosroshahi, M. J. Ansari, A. Habicht, M. Azuma, H. Yagita, R. J. Noelle, A. Coyle, A. L. Mellor, S. J. Khoury, and M. H. Sayegh. 2005. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J. Exp. Med. 202: 231-237.
40. Hori, J., M. Wang, M. Miyashita, K. Tanemoto, H. Takahashi, T. Takemori, K. Okumura, H. Yagita, and M. Azuma. 2006. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J. Immunol. 177: 5928-5935.
41. + T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation. Invest. Ophthalmol. Visual Sci. 47: 4444-4452.
42. Guleria, I., M. Gubbels Bupp, S. Dada, B. Fife, Q. Tang, M. J. Ansari, S. Trikudanathan, N. Vadivel, P. Fiorina, H. Yagita, et al. 2007. Mechanisms of PDL1-mediated regulation of autoimmune diabetes. Clin. Immunol. 125: 16-25.
43. Kanai, T., T. Totsuka, K. Uraushihara, S. Makita, T. Nakamura, K. Koganei, T. Fukushima, H. Akiba, H. Yagita, K. Okumura, et al. 2003. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171: 4156-4163.
44. Liang, S. C., Y. E. Latchman, J. E. Buhlmann, M. F. Tomczak, B. H. Horwitz, G. J. Freeman, and A. H. Sharpe. 2003. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33: 2706-2716.
45. Latchman, Y. E., S. C. Liang, Y. Wu, T. Chernova, R. A. Sobel, M. Klemm, V. K. Kuchroo, G. J. Freeman, and A. H. Sharpe. 2004. PD-L1-deficient mice show that PD-L1 on T cells, antigen presenting cells and host tissues negatively regulate T cells. Proc. Natl. Acad. Sci. USA. 101: 10691-10696.
46. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
47. Yanaba, K., J. D. Bouaziz, T. Matsushita, T. Tsubata, and T. F. Tedder. 2009. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 182: 7459-7472.
48. Bouaziz, J. D., K. Yanaba, and T. F. Tedder. 2008. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 224: 201-214.
49. Yanaba, K., J. D. Bouaziz, T. Matsushita, C. M. Magro, E. W. St Clair, and T. F. Tedder. 2008. B-lymphocyte contributions to human autoimmune disease. Immunol. Rev. 223: 284-299.
50. Wolf, S. D., B. N. Dittel, F. Hardardottir, C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278.
51. Pentcheva-Hoang, T., C. Lieping, D. M. Pardoll, and J. P. Allison. 2007. Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability. Proc. Natl. Acad. Sci. USA 104: 17765-17770.
52. Yamazaki, T., H. Akiba, H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D. M. Pardoll, K. Okumura, M. Azuma, and H. Yagita. 2002. Expression of programmed death 1 ligands by murine t cells and APC. J. Immunol. 169: 5538-5545.
53. Zhong, X., J. R. Tumang, W. Gao, C. Bai, and T. L. Rothstein. 2007. PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for VH11/VH12 and phosphatidylcholine binding. Eur. J. Immunol. 37: 2405-2410.
54. Trautmann, L., L. Janbazian, and N. Chomont. 2006. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
55. Wiesemann, E., M. Deb, C. Trebst, B. Hemmer, M. Stangel, and A. Windhagen. 2008. Effects of interferon-β on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-β treatment in patients with multiple sclerosis. Mult. Scler. 2: 166-176.
56. +PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy. FASEB J. 22: 3500-3508.
57. Zang, X., P. Loke, J. Kim, K. Murphy, R. Waitz, and J. P. Allison. 2003. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc. Natl. Acad. Sci. USA 100: 10388-10392.